Inhibitors of human plasmin derived from the kunitz domains

Details Inhibitors of human plasmin derived from the kunitz domains Inhibitors of human plasmin derived from the kunitz domains

2005-10-11

2005-10-11

Weber, Jon (Department: 1653)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S069200, C435S007100, C530S350000, C530S300000, C530S324000, C530S380000, C536S023500

Reexamination Certificate

active

06953674

ABSTRACT:
The invention features novel polypeptides homologous to the first Kunitz domain (K1) of lipoprotein associated coagulation inhibitor (LACI) that are capable of inhibiting plasmin, and nucleic acids encoding these proteins. The invention also features the use of such polypeptides in diagnostic, therapeutic and clinical methods.

REFERENCES:
patent: 4118481 (1978-10-01), Schnabel et al.
patent: 4153687 (1979-05-01), Schnabel et al.
patent: 4595674 (1986-06-01), Tschesche et al.
patent: 4657893 (1987-04-01), Krantz et al.
patent: 4845242 (1989-07-01), Powers et al.
patent: 5118668 (1992-06-01), Auerswald et al.
patent: 5166133 (1992-11-01), Houston et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5278144 (1994-01-01), Wolf et al.
patent: 5278285 (1994-01-01), Ebbers et al.
patent: 5373090 (1994-12-01), Norris et al.
patent: 5407915 (1995-04-01), Fritz et al.
patent: 5409895 (1995-04-01), Morishita et al.
patent: 5576294 (1996-11-01), Norris et al.
patent: 5583107 (1996-12-01), Wolf et al.
patent: 5589359 (1996-12-01), Innis et al.
patent: 5719041 (1998-02-01), Lazarus et al.
patent: 5736364 (1998-04-01), Kelley et al.
patent: 5770568 (1998-06-01), Auerswald et al.
patent: 5780265 (1998-07-01), Dennis et al.
patent: 5786328 (1998-07-01), Dennis et al.
patent: 5795865 (1998-08-01), Markland et al.
patent: 5795954 (1998-08-01), Lazarus et al.
patent: 5843895 (1998-12-01), Lazarus et al.
patent: 5994125 (1999-11-01), Markland et al.
patent: 6004579 (1999-12-01), Bathurst et al.
patent: 6010880 (2000-01-01), Markland et al.
patent: 6057287 (2000-05-01), Markland et al.
patent: 6071723 (2000-06-01), Markland et al.
patent: 6103499 (2000-08-01), Markland et al.
patent: 6333402 (2001-12-01), Markland et al.
patent: 6423498 (2002-07-01), Markland et al.
patent: 2004/0038893 (2004-02-01), Ladner et al.
patent: 2004/0053206 (2004-03-01), Cicardi et al.
patent: 0 486 001 (1992-05-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 93/14120 (1993-07-01), None
patent: WO 93/14121 (1993-07-01), None
patent: WO 93/14122 (1993-07-01), None
patent: WO 95/18830 (1995-07-01), None
patent: WO 95/21601 (1995-08-01), None
Brinkmann, T., and Tschesche, H., “Design of an Aprotinin Variant with Inhibitory Activity Against Chymotrypsin and Cathepsin G by Recombinant DNA Technology”,Biol. Chem. Hoppe-Seyler,vol. 371, pp. 43-52, 1990. (Item AZ2 on PTO-1449 Stamped Jan. 28, 2004).
Dennis, M.S. et al., “Potent and Selective Kunitz-Domain Inhibitors of Plasma Kallikrein Designed by Phage Display”,J. Biol. Chem., vol. 270, pp. 25411-25417, 1995. (Item AU2 on PTO-1449 Stamped Dec. 29, 2003).
Markland J. Cell. Biochem. Supp. O 18D:157, Abstract S 331 (1994) (Item AU3 on PTO-1449 Stamped Jan. 28, 2004).
Mathews, M.S. et al.,Biochemistry, The Benjamin/Cummings publishing Co., Inc., Redwood City, CA., pp. 208-212, 1990. (Item AV2 on PTO-1449 Stamped Dec. 29, 2003).
Ley, A.C. et al., “Obtaining a Family of High-Affinity, High-Specificity Protein Inhibitors of Plasmin and Plasma Kallikrein”,Molecular Diversity, vol. 2, pp. 119-124, 1996. (Item CA on PTO-1449 Stamped Sep. 2, 2003).
Adelman et al., Blood, 68(6):1280-1284 (1986).
Anba et al., Biochimia, 70(6):727-733 (1988).
Auerswald et al., Bio. Chem. Hoppe-Seyler, 369(Suppl):27-35 (1988).
Baneyx & Georglou, J. Bacteriol., 173(6):2696-2703 (1991).
Baneyx and Georgiou, J. Bacteriol., 172(1):491-494 (1990).
Browne et al., GenaBank, Accession No. M74220 (1991).
Broze et al., Biochemistry, 29(33):7539-7546 (1990).
Colman et al., Hemostasis and Thrombosis, Second Edition (Colman et al., eds; ISBN 0-397-50679-1) Chap. 1, pp. 3-17 (1987).
Dennis and Lazarus, J. Biological Chem., 269(35):22129-22136 (1994).
Dennis and Lazarus, J. Biological Chem., 269(35):22137-22144 (1994).
Eigenbrot et al., Protein Engineering, 3(7):591-598 (1990).
Ellis et al., Ann. NY Acad. Sci., 667:13-31 (1992).
Fidler and Ellis, Cell. 79:185-188 (1994).
Fraedflch et al., Thorac. Cardiovasc. Surg., 37(2):89-91 (1989).
Gardell, Toxicol. Pathol., 21(2):190-198 (1993).
Girard et al., J. Biol. Chem., 266(8):5036-5041 (1991).
Girard et al., Nature, 338:518-20 (1989).
Cregg et al. Bio/Technology, 11:905-910 (1993).
Hoover et al., Biochemistry, 32:10936-10943 (1993).
Hynes et al., Biochemistry, 29:10018-10022 (1990).
Kido et al., Biochem. & Biophys. Res. Comm., 167(2):716-721 (1990).
Kido et al., J. Biol. Chem., 263(34):18104-18107 (1988).
Kurjan and Herkowwitz, Cell, 30:933-943 (1982).
Laskowski and Kato, Ann. Rev. Biochem., 49:593-626 (1980).
Leatherbarrow and Salacinski, Biochemistry, 30(44):1071710721 (1991).
Lohmann and Marshall, Refract. Corneal. Surg. 9(4):300-302 (1993).
Lucas et al., J. Biological Chem., 258(7):4249-4256 (1983).
Mann and Lundblad, Hemostasis and Thrombosis, Second Edition (Colman et al., eds; ISBN 0-397-50679-1) Chap 10, pp. 148-161 (1987).
Miyajima et al., Gene, 37:155-161 (1985).
Neuhaus et al., Lancet, 2(8668)924-925 (1989).
Novotny et al., J. Biol. Chem., 264(31):18832-18837 (1989).
O'Reilly et al., Cell, 79:315-328 (1994).
Park and Tulinsky, Biochemistry, 25(14):3977-3982 (1986).
Putterman, Acta Chir. Scand., 155(6-7:)367 (1989).
Robbins, Hemostasis and Thrombosis, Second Edition (Colman et al., eds; ISBN 0-397-50679-1), Chap. 21, pp. 340-357 (1987).
Schechter and Berger, Biochem. Biophys. Res. Commun. 32(5):898-902 (1968).
Schechter and Berger, Biochem. Biophys. Res. Commun., 27(2):157-162 (1967).
Schnabel et al., Biol. Chem., Hoppe-Seyler, 367:1167-1176 (1986).
Sheridan et al., Dis. Colon Rectum, 32(6):505-508 (1989).
Sprecher et al., PNAS USA, 91:3353-3357 (1994).
Van Diji et al., EMBO J., 11(8):2819-2828 (1992).
Varadi and Patthy, Biochemistry, 23(9):2108-2112 (1984).
Varadi and Patthy, Biochemistry, 22(10):2440-2446 (1983).
Vedvick et al., J. Ind. Microbiol., 7:197-201 (1991).
Wagner et al., Biochem Biophy. Res. Comm., 186:1138-1145 (1992).
Wun et al., J. Biol. Chem. 263(13):6001-6004 (1988).
Markland, W., et al., “Selection for Protease Inhibitors Using Bacteriophage Display,”Methods Enzymol., 267, Combinatorial Chemistry, ed. J.N. Abelson, Academic Press, pp. 28-51 (1996).
Markland, W., et al., “Iterative Optimization of High-Affinity Protease Inhibitors Using Phage Display. I. Plasmin,”Biochemistry35(24):8045-8057 (1996).
Markland, W., et al., “Iterative Optimization of High-Affinity Protease Inhibitors Using Phage Display. 2. Plasma Kallikrein and Thrombin,”Biochemistry35(24):8058-8067 (1996).
Albrecht, G.J., et al., “Kunitz-Type Proteinase Inhibitors Derived by Limited Proteolysis of the Inter-α-Trypsin Inhibitor, IX[1-8],”Hoppe-Seyler's Z. Physiol. Chem., 364:1697-1702 (1983).
Beckmann, J., et al., “Preparation of Chemically ‘Mutated’ Aprotinin Homologues by Semisynthesis-P1Substitutions Change Inhibitory Specificity,”Eur. J. Biochem., 176: 675-682 (1988).
Dufton, M.J., “Proteinase Inhibitors and Dendrotoxins,”Eur. J. Biochem., 153:647-654 (1985).
Ganu, V.S., et al., “Improved Synthetic Inactivators of Plasmin,”Thromb. Res., 45:1-6 (1987).
Goldenberg, D.P., and Creighton, T.E., “Circular and Circularly Permuted Forms of Bovine Pancreatic Trypsin-Inhibitor,”J. Mol. Biol., 165: 407-13 (1983).
Roberts, B.L., et al., “Protease Inhibitor Display M13 Phage: Selection of High-affinity Neutrophil Elastase Inhibitors,”Gene, 121:9-15 (1992).
Roberts, B.L., et al., “Directed Evolution of a Protein: Selection of Potent Neutrophil Elastase Inhibitor Displayed on M13 Fusion Phage,”Proc. Natl. Acad. Sci USA., 89:2429-2433 (1992).
Schwarz, H., et al., “Stability Studies Studies on Derivatives of the Bovine Pancreatic Trypsin Inhibitor,”Biochemistry., 26:3544-51 (1987).
Tschesche, H., et al., “Semisynthetic Engineering of Proteinase Inhibitor Homologues,”Biochim. Biophys. Acta, 913:97-101 (1987).
Angliker, H., et al., “The Synthesis of Lysylfluoromethanes and Their Properties as Inhibitors of Trypsin, Plasmin and Cathepsin B,&#

Affiliated with

Also associated with

Rating

Inhibitors of human plasmin derived from the kunitz domains does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of human plasmin derived from the kunitz domains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of human plasmin derived from the kunitz domains will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3465230